RNXT logo

RenovoRx (RNXT) Company Overview

Profile

Full Name:

RenovoRx, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

August 26, 2021

Indexes:

Not included

Description:

RenovoRx (RNXT) is a biotechnology company focused on developing innovative treatments for cancer. They specialize in targeted therapies that deliver medication directly to tumors, aiming to improve patient outcomes and reduce side effects. Their approach combines advanced technology with a commitment to enhancing cancer care.

Events Calendar

Earnings

Next earnings date:

May 9, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 10, 24 Ascendiant Capital
Buy
Sep 12, 24 Ascendiant Capital
Buy
Jun 17, 24 Ascendiant Capital
Buy
Feb 2, 24 Alliance Global Partners
Buy
Nov 15, 23 Maxim Group
Hold
Aug 18, 23 Roth MKM
Buy
Nov 1, 21 Roth Capital
Buy
Oct 6, 21 Maxim Group
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for RenovoRx?
  • Does RenovoRx pay dividends?
  • What sector is RenovoRx in?
  • What industry is RenovoRx in?
  • What country is RenovoRx based in?
  • When did RenovoRx go public?
  • Is RenovoRx in the S&P 500?
  • Is RenovoRx in the NASDAQ 100?
  • Is RenovoRx in the Dow Jones?
  • When was RenovoRx's last earnings report?
  • When does RenovoRx report earnings?
  • Should I buy RenovoRx stock now?

What is the ticker symbol for RenovoRx?

The ticker symbol for RenovoRx is NASDAQ:RNXT

Does RenovoRx pay dividends?

No, RenovoRx does not pay dividends

What sector is RenovoRx in?

RenovoRx is in the Healthcare sector

What industry is RenovoRx in?

RenovoRx is in the Biotechnology industry

What country is RenovoRx based in?

RenovoRx is headquartered in United States

When did RenovoRx go public?

RenovoRx's initial public offering (IPO) was on August 26, 2021

Is RenovoRx in the S&P 500?

No, RenovoRx is not included in the S&P 500 index

Is RenovoRx in the NASDAQ 100?

No, RenovoRx is not included in the NASDAQ 100 index

Is RenovoRx in the Dow Jones?

No, RenovoRx is not included in the Dow Jones index

When was RenovoRx's last earnings report?

RenovoRx's most recent earnings report was on Nov 14, 2024

When does RenovoRx report earnings?

The next expected earnings date for RenovoRx is May 9, 2025

Should I buy RenovoRx stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions